Nakanishi Shotaro

写真a

Title

Lecturer

Researcher Number(JSPS Kakenhi)

40725321

Current Affiliation Organization 【 display / non-display

  • Duty   University of the Ryukyus   Hospital   Lecturer  

External Career 【 display / non-display

  • 2013.04
     
     

    University of the Ryukyus, Faculty of Medicine, University Hospital, Instructor  

Published Papers 【 display / non-display

  • Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan

    Nakanishi S, Fukushima Y, Inokuchi J, Hakariya T, Kakinoki H, Enokida H, Chikui K, Matsuoka H, Shin T, Mukai S, Kamba T, Eto M, Imamura R, Noguchi M, Igawa T, Haga N, Kamoto T, Fujimoto N, Saito S

    Int J Urol .     2024.05 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma

    Nakanishi S, Goya M, Suda T, Yonamine T, Sugawa A, Saito S

    BMC Urol .     2024.04 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • A case report of hereditary leiomyomatosis and renal cell carcinoma (HLRCC)

    Nohara S, Nakanishi S, Matsuo T, Tamaki T, Saito S.

    Urol Case Rep .     2024.04 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Prognostic impact of histological discordance between transurethral resection and radical cystectomy

    Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group.

    BJU Int .     2024 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site

    Nishiyama N, Kita Y, Ito K, Kato M, Hatakeyama S, Matsushita Y, Naito S, Miyake M, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Nishiyama H, Kobayashi T, Kitamura H; Japan Urological Oncology Group

    Anticancer Res     2023.11 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

display all >>